scispace - formally typeset
D

Dionysios Mitropoulos

Researcher at National and Kapodistrian University of Athens

Publications -  51
Citations -  973

Dionysios Mitropoulos is an academic researcher from National and Kapodistrian University of Athens. The author has contributed to research in topics: Bladder cancer & Cystectomy. The author has an hindex of 14, co-authored 51 publications receiving 752 citations. Previous affiliations of Dionysios Mitropoulos include Athens State University.

Papers
More filters
Journal ArticleDOI

Validation of the Clavien–Dindo Grading System in Urology by the European Association of Urology Guidelines Ad Hoc Panel

TL;DR: The Clavien-Dindo classification is a standardised approach to grade and report postoperative complications in urology and should be used systematically, however, it does not apply for intraoperative complications, and there is a need for an additional tool.
Journal ArticleDOI

Current Clinical Practice Guidelines for the Treatment of Renal Cell Carcinoma: A Systematic Review and Critical Evaluation

TL;DR: A systematic review of the existing guidelines in MEDLINE suggests that the combination of systematic review and critical evaluation can define practices of wide applicability and areas for future research by identifying areas of agreement and uncertainty among existing guidelines.
Journal ArticleDOI

Intraoperative Adverse Incident Classification (EAUiaiC) by the European Association of Urology ad hoc Complications Guidelines Panel.

TL;DR: Both the initial assessment of feasibility and the subsequent assessment of reliability suggest that the proposed EAUiaiC system is a simple and effective tool for classifying intraoperative complications.
Journal ArticleDOI

Treatment of patients with metastatic urothelial carcinoma and impaired renal function with single-agent docetaxel.

TL;DR: Preliminary data indicate that single-agent docetaxel therapy may represent an effective therapeutic alternative for patients with advanced urothelial carcinoma and renal insufficiency precluding cisplatin-based combination chemotherapy.